(Q53061383)
Statements
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy (English)
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy (English)
S. Lichtiger
D. G. Binion
D. C. Wolf
D. H. Present
A. G. Bensimon
E. Wu
A. P. Yu
A. T. Cardoso
J. Chao
P. M. Mulani
K. G. Lomax
28 September 2010
32
10
1228-1239
1 reference